Chemed (FRA:CXM) YoY EPS Growth: 43.88% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CXM Chemed Corp FRA:CXM
86 GF Score
Price €442.00
GF Value €583.62
! 7 Warning Signs
View Full Analysis

What is Chemed YoY EPS Growth?

Chemed FRA:CXM -0.45% 86 YoY EPS Growth is 43.88% as of Jun. 2026. GuruFocus rates FRA:CXM with a GF Score™ of 86/100 and a GF Value™ of €583.62. The stock has 7 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Chemed's YoY EPS Growth for the quarter that ended in Jun. 2026 was 43.88%.

Chemed's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was €4.45.

Chemed YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Chemed's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemed YoY EPS Growth Chart

Chemed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.88 4.64 5.37 15.53 -17.55

Chemed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.36 -15.65 -18.59 -6.85 43.88
FRA:CXM
86GF Score
Chemed Corp FRA:CXM
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemed YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Chemed's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(15.662-18.995)/ | 18.995 |
=-17.55 %

Chemed's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(4.453-3.095)/ | 3.095 |
=43.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 43.88% mean?
Chemed (FRA:CXM) has a YoY EPS Growth of 43.88% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Chemed and its competitors.
Is Chemed's YoY EPS Growth too high?
Chemed's current YoY EPS Growth is 43.88%. Overall, Chemed has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Chemed's YoY EPS Growth compare to PACS and LFST?
Chemed's YoY EPS Growth of 43.88% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Chemed and its competitors. Chemed's current YoY EPS Growth is 43.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemed stock overvalued right now?
Chemed (FRA:CXM) has a current YoY EPS Growth of 43.88%. The stock's GF Value™ is €583.62, compared to a current price of €442.00 — trading 24.3% below its estimated fair value. The current YoY EPS Growth is 43.88%. Chemed's overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Chemed (FRA:CXM), the current YoY EPS Growth is 43.88% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemed (FRA:CXM) Overvalued in 2026?

Based on GuruFocus' analysis, Chemed stock appears to be undervalued. The current stock price of €442.00 is trading 24.3% below its estimated GF Value™ of €583.62.

Key valuation signals for FRA:CXM:

  • YoY EPS Growth: 43.88%
  • GF Value™: €583.62 vs. price of €442.00 (24.3% below fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the FRA:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemed Business Description

Other Exchanges CHE:USA
Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
86GF Score

Get the complete analysis for FRA:CXM

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€442.00
Price
€583.62
GF Value